Cargando…

Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells

INTRODUCTION: Patients with persistently active autoimmune diseases are considered to be candidates for autologous SCT. We performed a phase 1/2 study in a limited number of patients who were refractory to conventional immunosuppressive treatment. Following a period of uncontrolled disease activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosen, Oliver, Thiel, Andreas, Massenkeil, Gero, Hiepe, Falk, Häupl, Thomas, Radtke, Hartmut, Burmester, Gerd R, Gromnica-Ihle, Erika, Radbruch, Andreas, Arnold, Renate
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC17815/ https://www.ncbi.nlm.nih.gov/pubmed/11056673

Ejemplares similares

Long term immune reconstitution after immunoablation and autologous CD34 cell therapy in autoimmune diseases
por: Thiel, AT, et al.
Publicado: (2002)

Establishment of juvenile and tolerant immune systems in patients with autoimmune diseases treated with immunoablation and autologous stem cell therapy
por: Radbruch, A, et al.
Publicado: (2003)

Long-term immune reconstitution after autologous stem-cell transplantation for severe autoimmune diseases
por: Alexander, T, et al.
Publicado: (2005)

In vivo preactivated autoreactive Th cells in healthy individuals
por: Radbruch, A, et al.
Publicado: (2001)

Long-term immune reconstitution in patients treated with autologous stem cell transplantation for refractory autoimmune diseases
por: Alexander, T, et al.
Publicado: (2004)

Impact of cellular therapies on autoreactive, long-lived plasma cells in autoimmune diseases (AID)
por: Hiepe, F, et al.
Publicado: (2004)

Perspectives and limitations of gene expression profiling in rheumatology: new molecular strategies
por: Häupl, Thomas, et al.
Publicado: (2004)

Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan
por: Leoni, Giampaolo, et al.
Publicado: (2014)

Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice
por: Khodadadi, Laleh, et al.
Publicado: (2015)

Chemo-immunoablation of solid tumors: A new concept in tumor ablation
por: Meng, Liangliang, et al.
Publicado: (2023)

SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome
por: Rose, Thomas, et al.
Publicado: (2016)

Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference?
por: Kyogoku, Chieko, et al.
Publicado: (2013)

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
por: Alexander, Tobias, et al.
Publicado: (2015)

Pathogenic memory plasma cells in autoimmunity
por: Chang, Hyun-Dong, et al.
Publicado: (2019)

The Maintenance of Memory Plasma Cells
por: Khodadadi, Laleh, et al.
Publicado: (2019)

SiPaGene: A new repository for instant online retrieval, sharing and meta-analyses of GeneChip(® )expression data
por: Menßen, Adriane, et al.
Publicado: (2009)

Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis
por: Smith, Michael F, et al.
Publicado: (2009)

Immunoablation and Stem Cell Transplantation in Amyotrophic Lateral Sclerosis: The Ultimate Test for the Autoimmune Pathogenesis Hypothesis
por: Leis, A. Arturo, et al.
Publicado: (2016)

In vivo cell kinetics in breast carcinogenesis
por: Bai, Maria, et al.
Publicado: (2001)

Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low – results from RABBIT, the German biologics register
por: Listing, Joachim, et al.
Publicado: (2006)

Therapeutic inhibition of proteasomes in systemic lupus erythematosus
por: Hiepe, Falk, et al.
Publicado: (2011)

Depleting TMED3 alleviates the development of endometrial carcinoma
por: Zhang, Jin, et al.
Publicado: (2022)

Inhibition of the angiogenesis and growth of Aloin in human colorectal cancer in vitro and in vivo
por: Pan, Qin, et al.
Publicado: (2013)

Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo
por: Wang, Lei, et al.
Publicado: (2014)

Characterization of kidney infiltrating T cells in the NZB/W F1 lupus model
por: Enghard, P, et al.
Publicado: (2004)

Monocytes and Macrophages in Synovitis: Villains or Victims?
por: Burmester, Gerd R, et al.
Publicado: (2000)

Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors
por: Taddeo, Adriano, et al.
Publicado: (2015)

Knockdown of MCM8 inhibits development and progression of bladder cancer in vitro and in vivo
por: Zhu, Wei, et al.
Publicado: (2021)

Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)
por: Tsui, Sam-Mui, et al.
Publicado: (2009)

Frequent induction of chromosomal aberrations in in vivo skin fibroblasts after allogeneic stem cell transplantation: hints to chromosomal instability after irradiation
por: Massenkeil, G., et al.
Publicado: (2015)

Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
por: Dai, Zhi-Jun, et al.
Publicado: (2012)

Ethanol extract of Ligustrum lucidum Ait. leaves suppressed hepatocellular carcinoma in vitro and in vivo
por: Tian, Guoyan, et al.
Publicado: (2019)

Altered expression of T cell Immunoglobulin-Mucin (Tim) molecules in peripheral blood mononuclear cells in aplastic anemia
por: Liu, Xin, et al.
Publicado: (2014)

In vivo UVA irradiation of mouse is more efficient in promoting pulmonary melanoma metastasis than in vitro
por: Pastila, Riikka, et al.
Publicado: (2011)

Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo
por: Cheung, Phyllis Fung-Yi, et al.
Publicado: (2014)

Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo
por: Que, Zujun, et al.
Publicado: (2019)

Integrative analysis of multi-omics data to detect the underlying molecular mechanisms for obesity in vivo in humans
por: Zhang, Qiang, et al.
Publicado: (2022)

Pancratistatin induces apoptosis in clinical leukemia samples with minimal effect on non-cancerous peripheral blood mononuclear cells
por: Griffin, Carly, et al.
Publicado: (2010)

Type 1 regulatory T cells in treatment of murine lupus
por: Undeutsch, R, et al.
Publicado: (2005)

Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models
por: Hijona, Elizabeth, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kp9d5b8iok4onpgirno5jgjcjg